EUVIMEDEUVIMED entdecken
Crossref

Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates

Takahiro Akasaka, Hiroyuki Watanabe iD, Masahiro Ono iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Takahiro Akasaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Ky…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Amyloid beta-Peptides, Boron Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Support for Pioneering Research Initiated by the Next Generation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soluble amyloid β (Aβ) aggregates have attracted attention as therapeutic targets and biomarkers of Alzheimer's disease. We previously reported a fluorescent probe, BAOP-16, which targets soluble Aβ aggregates. However, its limited aqueous solubility has hindered its application in biological assays. In this study, we developed aqueous-soluble fluorescent probes that target soluble Aβ aggregates. Among the synthesized candidates, sBAOP-2-3, which is substituted with two CH2C-Tf2 groups and a diphenyl amino group, exhibited markedly improved aqueous solubility compared with BAOP-16. It also showed a marked increase in fluorescence intensity in the presence of Aβ oligomers, and the highest selectivity for Aβ oligomers over Aβ fibrils. During the aggregation process of Aβ, sBAOP-2-3 detected soluble Aβ aggregates in an early phase. Furthermore, staining experiments using mouse brain sections suggested that sBAOP-2-3 selectively stained soluble Aβ aggregates in mouse brains. These results suggest that sBAOP-2-3 shows promise as a probe for the selective detection of soluble Aβ aggregates in biological systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesAmyloid beta-PeptidesBoron CompoundsAnimalsSolubilityMiceBrainAlzheimer DiseaseHumansProtein AggregatesPeptide Fragments

Stichwörter der Autor:innen

Alzheimer’s diseaseaqueous solubilitybiological applicationfluorescent probesection stainingsoluble amyloid β aggregates

Substanzen

Fluorescent DyesAmyloid beta-PeptidesBoron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneProtein AggregatesPeptide Fragments

Autor:innen und Institutionen

  • Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

ORCID-Profile: Hiroyuki Watanabe, Masahiro Ono

Förderung

  • Japan Society for the Promotion of Science
  • Support for Pioneering Research Initiated by the Next Generation

Zitieren

APA

Akasaka, T., Watanabe, H., & Ono, M. (2025). Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00525

Vancouver

Akasaka T, Watanabe H, Ono M. Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00525

BibTeX
@article{Akasaka2025,
  author = {Akasaka, Takahiro and Watanabe, Hiroyuki and Ono, Masahiro},
  title = {Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00525}
}
Kostenlos starten →